Back to available technologies

Alteration of Dendritic Cell Metabolism to Augment Cancer Vaccine Efficacy

We have discovered a novel biochemical signaling pathway that is responsible for maintaining immune tolerance. Our data suggest that either the pharmacologic or genetic manipulation of an enzyme involved in this pathway provides a potent strategy for enhancing the ability of the immune system to destroy cancer.

Duke File (IDF) Number

T-004727

Inventor(s)

  • Hanks, Brent
  • Zhao, Fei

For more information please contact

College

School of Medicine (SOM)

Interested in this Technology?

Submit your interest below.